First-in-Human Study of TAK-280 in Participants With Solid Tumors

Chris O'Brien Lifehouse Hospital, Camperdown

Cabrini Health, Malvern

Monash Medical Centre, Clayton

Southern Oncology Clinical Research Unit, Bedford Park

Duke Cancer Institute, Durham

START MADRID_Hospital Universitario Fundacion Jimenez Diaz, Madrid

Hospital Universitario 12 de Octubre, Madrid

Hospital Universitario Virgen de la Victoria, Málaga

SCRI Tennessee Oncology Nashville, Nashville

Hospital Clinico Universitario de Valencia, Valencia

Froedtert and The Medical College of Wisconsin, Milwaukee

University of Minnesota - Masonic Cancer Center, Minneapolis

Avera Cancer Institute, Sioux Falls

University of Arkansas For Medical Sciences, Little Rock

The University of Texas MD Anderson Cancer Center, Houston

University of California San Francisco, San Francisco

The Cleveland Clinic Foundation, Cleveland

Sanford Cancer Center, Sioux Falls

Centre Intégré de Cancérologie du CHU de Québec - Université Laval, Québec

Centre Hospitalier Universitaire de Sherbrooke CHUS, Sherbrooke

Hospital Quironsalud Barcelona, NEXT Oncology, Barcelona

Hospital Universitari Dexeus - Grupo Quironsalud, Barcelona

Instituto de Investigacion Oncologica Vall dHebron (VHIO) - EPON, Barcelona